IL-10: A multifunctional cytokine in viral infections

Journal of Immunology Research

Volumn 2017, Issue , 2017, Pages

  Rojas, José M ^a   Avia, Miguel ^a   Martín, Verónica ^a   Sevilla, Noemí ^a  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PERSISTENT INFECTION; REVIEW; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; HOMEOSTASIS; IMMUNE EVASION; IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; VIRUS LATENCY;

ANIMALS; HOMEOSTASIS; HUMANS; IMMUNE EVASION; IMMUNITY; IMMUNOMODULATION; INTERLEUKIN-10; T-LYMPHOCYTES; VIRUS DISEASES; VIRUS LATENCY;

EID: 85016923746     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2017/6104054     Document Type: Review

References (204)

1. W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "Regulation and functions of the IL-10 family of cytokines in inflammation and disease, " Annual Review of Immunology, vol. 29, pp. 71-109, 2011.
2. D. G. Brooks, M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone, "Interleukin-10 determines viral clearance or persistence in vivo, " Nature Medicine, vol. 12, no. 11, pp. 1301-1309, 2006.
3. Y. Liu, S. H.-Y.Wei, A. S.-Y. Ho, R. De Waal Malefyt, and K.W. Moore, "Expression cloning and characterization of a human 11-10 receptor, " Journal of Immunology, vol. 152, no. 4, pp. 1821-1829, 1994.
4. K. W. Moore, R. De Waal Malefyt, R. L. Coffman, and A. O'Garra, "Interleukin-10 and the interleukin-10 receptor, " Annual Review of Immunology, vol. 19, pp. 683-765, 2001.
5. J. K. Riley, K. Takeda, S. Akira, and R.D. Schreiber, "Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for antiinflammatory action, " Journal of Biological Chemistry, vol. 274, no. 23, pp. 16513-16521, 1999.
6. M. A. Meraz, J. M. White, K. C. F. Sheehan et al., "Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, " Cell, vol. 84, no. 3, pp. 431-442, 1996.
7. A. S.-Y. Ho, S. H.-Y. Wei, A. L.-F. Mui, A. Miyajima, and K. W. Moore, "Functional regions of the mouse interleukin-10 receptor cytoplasmic domain, " Molecular and Cellular Biology, vol. 15, no. 9, pp. 5043-5053, 1995.
8. D. F. Fiorentino, M.W. Bond, and T. R. Mosmann, "Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, " Journal of Experimental Medicine, vol. 170, no. 6, pp. 2081-20095, 1989.
9. K. N. Couper, D. G. Blount, and E.M. Riley, "IL-10: themaster regulator of immunity to infection, " Journal of Immunology, vol. 180, no. 9, pp. 5771-5777, 2008.
10. P. Shen and S. Fillatreau, "Suppressive functions of B cells in infectious diseases, " International Immunology, vol. 27, no. 10, pp. 513-519, 2015.
11. H. Tilg, C. Van Montfrans, A. Van den Ende et al., "Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ, " Gut, vol. 50, no. 2, pp. 191-195, 2002.
12. F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. H. Van Deventer, and T. Van der Poll, "Proinflammatory effects of IL-10 during human endotoxemia, " Journal of Immunology, vol. 165, no. 5, pp. 2783-2789, 2000.
13. D. J. Cua, B. Hutchins, D.M. LaFace, S. A. Stohlman, and R. L. Coffman, "Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis, " Journal of Immunology, vol. 166, no. 1, pp. 602-608, 2001.
14. E. Bettelli, M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo, "IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10-and IL-4-deficient and transgenic mice, " Journal of Immunology, vol. 161, no. 7, pp. 3299-3306, 1998.
15. F. J. Barrat, D. J. Cua, A. Boonstra et al., "In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines, " Journal of Experimental Medicine, vol. 195, no. 5, pp. 603-616, 2002.
16. L. R. Leon, W. Kozak, and M. J. Kluger, "Role of IL-10 in inflammation-studies using cytokine knockout mice, " Annals of the New York Academy of Sciences, vol. 856, pp. 69-75, 1998.
17. R. K. Sellon, S. Tonkonogy, M. Schultz et al., "Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, " Infection and Immunity, vol. 66, no. 11, pp. 5224-5231, 1998.
18. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller, "Interleukin-10-deficient mice develop chronic enterocolitis, " Cell, vol. 75, no. 2, pp. 263-274, 1993.
19. S. Rakoff-Nahoum, L. Hao, and R. Medzhitov, "Role of tolllike receptors in spontaneous commensal-dependent colitis, " Immunity, vol. 25, no. 2, pp. 319-329, 2006.
20. N. Hoshi, D. Schenten, S. A. Nish et al., "MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice, " Nature Communications, vol. 3, article no. 1120, 2012.
21. H. H. Uhlig, J. Coombes, C. Mottet et al., "Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis, " Journal of Immunology, vol. 177, no. 9, pp. 5852-5860, 2006.
22. Y. P. Rubtsov, J. P. Rasmussen, E. Y. Chi et al., "Regulatory T cellderived interleukin-10 limits inflammation at environmental interfaces, " Immunity, vol. 28, no. 4, pp. 546-558, 2008.
23. A. Chaudhry, R. M. Samstein, P. Treuting et al., "Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation, " Immunity, vol. 34, no. 4, pp. 566-578, 2011.
24. E. Zigmond, B. Bernshtein, G. Friedlander et al., "Macrophagerestricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis, " Immunity, vol. 40, no. 5, pp. 720-733, 2014.
25. M. Murai, O. Turovskaya, G. Kim et al., "Interleukin 10 acts on regulatory t cells to maintain expression of the transcription factor foxp3 and suppressive function in mice with colitis, " Nature Immunology, vol. 10, no. 11, pp. 1178-1184, 2009.
26. D. S. Shouval, A. Biswas, J. A. Goettel et al., "Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function, " Immunity, vol. 40, no. 5, pp. 706-719, 2014.
27. A. M. Beebe, D. J. Cua, and R. De Waal Malefyt, "The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) andmultiple sclerosis (MS), " Cytokine and Growth Factor Reviews, vol. 13, no. 4-5, pp. 403-412, 2002.
28. H. Hata, N. Sakaguchi, H. Yoshitomi et al., "Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice, " Journal of Clinical Investigation, vol. 114, no. 4, pp. 582-588, 2004.
29. X. Bai, J. Zhu, G. Zhang et al., "IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses, " Clinical Immunology and Immunopathology, vol. 83, no. 2, pp. 117-126, 1997.
30. S. Tartey and O. Takeuchi, "Pathogen recognition and Tolllike receptor targeted therapeutics in innate immune cells, " International Reviews of Immunology, pp. 1-17, 2017.
31. M. Ejrnaes, C. M. Filippi, M. M. Martinic et al., "Resolution of a chronic viral infection after interleukin-10 receptor blockade, " Journal of ExperimentalMedicine, vol. 203, no. 11, pp. 2461-2472, 2006.
32. S. S. M. Ng, A. Li, G. N. Pavlakis, K. Ozato, and T. Kino, "Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications, " PLOS ONE, vol. 8, no. 5, Article ID e63587, 2013.
33. R. Samarasinghe, P. Tailor, T. Tamura, T. Kaisho, S. Akira, and K. Ozato, "Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling, " Journal of Interferon and Cytokine Research, vol. 26, no. 12, pp. 893-900, 2006.
34. M. Javad Aman, T. Tretter, I. Eisenbeis et al., "Interferon-α stimulates production of interleukin-10 in activated CD4+ T cells and monocytes, " Blood, vol. 87, no. 11, pp. 4731-4736, 1996.
35. E. Y. Chang, B. Guo, S. E. Doyle, and G. Cheng, "Cutting edge: involvement of the type I IFNproduction and signaling pathway in lipopolysaccharide-induced IL-10 production, " Journal of Immunology, vol. 178, no. 11, pp. 6705-6709, 2007.
36. M. J. Pattison, K. F. MacKenzie, and J. S. C. Arthur, "Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback, " Journal of Immunology, vol. 189, no. 6, pp. 2784-2792, 2012.
37. A. Boonstra, R. Rajsbaum, M. Holman et al., "Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88-and TRIFdependent TLR signals, and TLR-independent signals, " Journal of Immunology, vol. 177, no. 11, pp. 7551-7558, 2006.
38. A. Howes, C. Taubert, S. Blankley et al., "Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages, " The Journal of Immunology, vol. 197, no. 7, pp. 2838-2853, 2016.
39. K. F. MacKenzie, K. Clark, S. Naqvi et al., "PGE2 induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway, " Journal of Immunology, vol. 190, no. 2, pp. 565-577, 2013.
40. A. D. Edwards, S. P. Manickasingham, R. Spörri et al., "Microbial recognition via toll-like receptor-dependent and-independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering, " Journal of Immunology, vol. 169, no. 7, pp. 3652-3660, 2002.
41. X. Hu, P. K. Paik, J. Chen et al., "IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins, " Immunity, vol. 24, no. 5, pp. 563-574, 2006.
42. M. G. Brown, A. O. Dokun, J. W. Heusel et al., "Vital involvement of a natural killer cell activation receptor in resistance to viral infection, " Science, vol. 292, no. 5518, pp. 934-937, 2001.
43. H. E. Farrell, K. Bruce, C. Lawler et al., "Type 1 interferons and NK cells limit murine cytomegalovirus escape from the lymph node subcapsular sinus, " PLOS Pathogens, vol. 12, no. 12, Article ID e1006069, 2016.
44. C. Lawler, C. S. Tan, J. P. Simas, P. G. Stevenson, and R. M. Longnecker, "Type I interferons and NK cells restrict gammaherpesvirus lymph node infection, " Journal of Virology, vol. 90, no. 20, pp. 9046-9057, 2016.
45. O. Chijioke, A. Müller, R. Feederle et al., "Human natural killer cells prevent infectious mononucleosis features by targeting lytic epstein-barr virus infection, " Cell Reports, vol. 5, no. 6, pp. 1489-1498, 2013.
46. C. Qian, X. Jiang, H. An et al., "TLR agonists promote ERKmediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation, " Blood, vol. 108, no. 7, pp. 2307-2315, 2006.
47. S. Mocellin, M. Panelli, E. Wang et al., "IL-10 stimulatory effects on humanNKcells explored by gene profile analysis, "Genes and Immunity, vol. 5, no. 8, pp. 621-630, 2004.
48. G. Cai, R. A. Kastelein, and C. A. Hunter, "IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18, " European Journal of Immunology, vol. 29, no. 9, pp. 2658-2665, 1999.
49. W. E. Carson, M. J. Lindemann, R. Baiocchi et al., "The functional characterization of interleukin-10 receptor expression on human natural killer cells, " Blood, vol. 85, no. 12, pp. 3577-3585, 1995.
50. Y. Shibata, L. A. Foster, M. Kurimoto et al., "Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ, " Journal of Immunology, vol. 161, no. 8, pp. 4283-4288, 1998.
51. B.-C. Chiu, V. R. Stolberg, and S. W. Chensue, "Mononuclear phagocyte-derived IL-10 suppresses the innate IL-12/IFN-γ axis in lung-challenged aged mice, " Journal of Immunology, vol. 181, no. 5, pp. 3156-3166, 2008.
52. M. J. Scott, J. J. Hoth, M. Turina, D. R. Woods, and W. G. Cheadle, "Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection, " Cytokine, vol. 33, no. 2, pp. 79-86, 2006.
53. M. A. Stacey, M. Marsden, E. C. Y. Wang, G. W. G. Wilkinson, and I. R. Humphreys, "IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection, " Journal of Immunology, vol. 187, no. 6, pp. 2944-2952, 2011.
54. J. H. Bream, R. E. Curiel, C.-R. Yu et al., "IL-4 synergistically enhances both IL-2-and IL-12-induced IFN-γ expression in murine NK cells, " Blood, vol. 102, no. 1, pp. 207-214, 2003.
55. M. Bodas, N. Jain, A. Awasthi et al., "Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy, " Journal of Immunology, vol. 177, no. 7, pp. 4636-4643, 2006.
56. M. J. Loza and B. Perussia, "The IL-12 signature: NK cell terminal CD56+high stage and effector functions, " Journal of Immunology, vol. 172, no. 1, pp. 88-96, 2004.
57. L. R. Grant, Z.-J. Yao, C. M. Hedrich et al., "Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells, " Genes and Immunity, vol. 9, no. 4, pp. 316-327, 2008.
58. P. J. Gaddi, M. J. Crane, M. Kamanaka, R. A. Flavell, G. S. Yap, and T. P. Salazar-Mather, "IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection, " PLoS ONE, vol. 7, no. 8, Article ID e42850, 2012.
59. S.-H. Lee, K.-S. Kim, N. Fodil-Cornu, S. M. Vidal, and C. A. Biron, "Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection, " Journal of Experimental Medicine, vol. 206, no. 10, pp. 2235-2251, 2009.
60. A. Maroof, L. Beattie, S. Zubairi, M. Svensson, S. Stager, and P. M. Kaye, "Posttranscriptional regulation of Il10 gene expression allows natural killer cells to express immunoregulatory function, " Immunity, vol. 29, no. 2, pp. 295-305, 2008.
61. R. Maldonado-López and M. Moser, "Dendritic cell subsets and the regulation ofTh1/Th2 responses, " Seminars in Immunology, vol. 13, no. 5, pp. 275-282, 2001.
62. D. Y. Ma and E. A. Clark, "Therole of CD40 and CD154/CD40L in dendritic cells, " Seminars in Immunology, vol. 21, no. 5, pp. 265-272, 2009.
63. S. S. Puntambekar, C. C. Bergmann, C. Savarin et al., "Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis, " Journal of Virology, vol. 85, no. 13, pp. 6702-6713, 2011.
64. M. Saraiva and A. O'Garra, "The regulation of IL-10 production by immune cells, " Nature Reviews Immunology, vol. 10, no. 3, pp. 170-181, 2010.
65. C. L. Maynard and C. T. Weaver, "Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation, " Immunological Reviews, vol. 226, no. 1, pp. 219-233, 2008.
66. S. S. Cush, G. V. Reynoso, O. Kamenyeva, J. R. Bennink, J. W. Yewdell, and H. D. Hickman, "Locally produced IL-10 limits cutaneous vaccinia virus spread, " PLOS Pathogens, vol. 12, no. 3, Article ID e1005493, 2016.
67. L. Jiang, S. Yao, S. Huang, J. Wright, T. J. Braciale, and J. Sun, "Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection, " European Journal of Immunology, vol. 46, no. 12, pp. 2778-2788, 2016.
68. J. Sun, R. Madan, C. L. Karp, and T. J. Braciale, "Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10, " Nature Medicine, vol. 15, no. 3, pp. 277-284, 2009.
69. K. Trandem, J. Zhao, E. Fleming, and S. Perlman, "Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis, " Journal of Immunology, vol. 186, no. 6, pp. 3642-3652, 2011.
70. J. Loebbermann, C. Schnoeller, H. Thornton et al., "IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice, " PLoSONE, vol. 7, no. 2, Article ID e32371, 2012.
71. E. M. Palmer, B. C. Holbrook, S. Arimilli, G. D. Parks, and M. A. Alexander-Miller, "IFNγ-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment, " Virology, vol. 404, no. 2, pp. 225-230, 2010.
72. I. A. Parish, H. D. Marshall, M. M. Staron et al., "Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1, " Journal of Clinical Investigation, vol. 124, no. 8, pp. 3455-3468, 2014.
73. H1 cells control themselves by producing interleukin-10, " Nature Reviews Immunology, vol. 7, no. 6, pp. 425-428, 2007.
74. +T cells: a critical mechanism for protection from severe immunopathology during malaria infection, " Journal of Immunology, vol. 188, no. 3, pp. 1178-1190, 2012.
75. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection, " Journal of Experimental Medicine, vol. 204, no. 2, pp. 273-283, 2007.
76. K. Richter, G. Perriard, R. Behrendt et al., "Macrophage and T cell produced IL-10 promotes viral chronicity, " PLoS Pathogens, vol. 9, no. 11, Article ID e1003735, 2013.
77. I. R. Humphreys, C. De Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware, "Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands, " Journal of Experimental Medicine, vol. 204, no. 5, pp. 1217-1225, 2007.
78. S. Redpath, A. Angulo, N. R. J. Gascoigne, and P. Ghazal, "Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10, " Journal of Immunology, vol. 162, no. 11, pp. 6701-6707, 1999.
79. + T cells are governed by type-I IFN-induced IL-27 and promote virus persistence, " PLOS Pathogens, vol. 12, no. 12, p. e1006050, 2016.
80. S. Rutz and W. Ouyang, "Regulation of interleukin-10 expression, " in Regulation of Cytokine Gene Expression in Immunity and Diseases, vol. 941 of Advances in ExperimentalMedicine and Biology, pp. 89-116, Springer, Dordrecht, Netherlands, 2016.
81. M. Kubo and Y. Motomura, "Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells, " Frontiers in Immunology, vol. 3, article 275, 2012.
82. A. Awasthi, Y. Carrier, J. P. S. Peron et al., "A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells, " Nature Immunology, vol. 8, no. 12, pp. 1380-1389, 2007.
83. M. Batten, N. M. Kljavin, J. Li, M. J. Walter, F. J. De Sauvage, and N. Ghilardi, "Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells, " Journal of Immunology, vol. 180, no. 5, pp. 2752-2756, 2008.
84. D. C. Fitzgerald, G. X. Zhang, M. El-Behi et al., "Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells, " Nature Immunology, vol. 8, no. 12, pp. 1372-1379, 2007.
85. + T cells, " Journal of Immunology, vol. 183, no. 4, pp. 2435-2443, 2009.
86. L. Zhang, S. Yuan, G. Cheng, and B. Guo, "Type I IFNpromotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation, " PLoS ONE, vol. 6, no. 12, Article ID e28432, 2011.
87. M. K. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. De Waal Malefyt, and M.-G. Roncarolo, "IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells, " Journal of Immunology, vol. 166, no. 9, pp. 5530-5539, 2001.
88. J. S. Stumhofer, J. S. Silver, A. Laurence et al., "Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, " Nature Immunology, vol. 8, no. 12, pp. 1363-1371, 2007.
89. - precursor cells in the absence of interleukin 10, " Nature Immunology, vol. 8, no. 9, pp. 931-941, 2007.
90. D.G. Brooks, L. Teyton, M.B.A. Oldstone, and D.B. McGavern, "Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection, " Journal of Virology, vol. 79, no. 16, pp. 10514-10527, 2005.
91. A. Gallimore, A. Glithero, A. Godkin et al., "Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes, " Journal of Experimental Medicine, vol. 187, no. 9, pp. 1383-1393, 1998.
92. + T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs, " Nature Immunology, vol. 12, no. 4, pp. 327-334, 2011.
93. T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser, "Effect of interleukin-10 on dendritic cell maturation and function, " European Journal of Immunology, vol. 27, no. 5, pp. 1229-1235, 1997.
94. F. Capsoni, F. Minonzio, A. M. Ongari, V. Carbonelli, A. Galli, and C. Zanussi, "IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ, " Journal of Leukocyte Biology, vol. 58, no. 3, pp. 351-358, 1995.
95. D. F. Fiorentino, A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra, "IL-10 inhibits cytokine production by activated macrophages, " Journal of Immunology, vol. 147, no. 11, pp. 3815-3822, 1991.
96. N. Makita, Y. Hizukuri, K. Yamashiro, M. Murakawa, and Y. Hayashi, "IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration, " International Immunology, vol. 27, no. 3, pp. 131-141, 2015.
97. S. Corinti, C. Albanesi, A. La Sala, S. Pastore, and G. Girolomoni, "Regulatory activity of autocrine IL-10 on dendritic cell functions, " Journal of Immunology, vol. 166, no. 7, pp. 4312-4318, 2001.
98. S. Bhattacharyya, P. Sen, M. Wallet, B. Long, A. S. Baldwin Jr., and R. Tisch, "Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IκB kinase activity, " Blood, vol. 104, no. 4, pp. 1100-1109, 2004.
99. F. O. Martinez and S. Gordon, "The M1 and M2 paradigm of macrophage activation: time for reassessment, " F1000Prime Reports, vol. 6, article 13, 2014.
100. A. D'Andrea, M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri, "Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, " Journal of ExperimentalMedicine, vol. 178, no. 3, pp. 1041-1048, 1993.
101. X. Ma, W. Yan, H. Zheng et al., "Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells, " F1000Research, vol. 4, 2015.
102. L. Gabryšová, K. S. Nicolson, H. B. Streeter et al., "Negative feedback control of the autoimmune response through antigeninduced differentiation of IL-10-secreting Th1 cells, " Journal of Experimental Medicine, vol. 206, no. 8, pp. 1755-1767, 2009.
103. C. Demangel, P. Bertolino, and W. J. Britton, "Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production, " European Journal of Immunology, vol. 32, no. 4, pp. 994-1002, 2002.
104. Y. Tian, S. B. Mollo, L. E. Harrington, and A. J. Zajac, "IL-10 regulates memory T cell development and the balance between Th1 and follicular Th cell responses during an acute viral infection, "The Journal of Immunology, vol. 197, no. 4, pp. 1308-1321, 2016.
105. X. S. Liu, Y. Xu, L. Hardy et al., "IL-10 mediates suppression of the CD8 T cell IFN-γ response to a novel viral epitope in a primed host, " The Journal of Immunology, vol. 171, no. 9, pp. 4765-4772, 2003.
106. L. Snell, I. Osokine, D. Yamada, J. De La Fuente, H. Elsaesser, and D. Brooks, "OvercomingCD4Th1cell fate restrictions to sustain antiviral CD8 T cells and control persistent virus infection, " Cell Reports, vol. 16, no. 12, pp. 3286-3296, 2016.
107. D. G. Brooks, K. B. Walsh, H. Elsaesser, and M. B. A. Oldstone, "IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3018-3023, 2010.
108. K. Richter and A. Oxenius, "Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement, " European Journal of Immunology, vol. 43, no. 9, pp. 2349-2360, 2013.
109. K. A. Kulcsar, V. K. Baxter, I. P. Greene, and D. E. Griffin, "Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 45, pp. 16053-16058, 2014.
110. K. E. Foulds, M. J. Rotte, and R. A. Seder, "IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection, " The Journal of Immunology, vol. 177, no. 4, pp. 2565-2574, 2006.
111. W. Cui, Y. Liu, J. S. Weinstein, J. Craft, and S. M. Kaech, "An Interleukin-21-Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells, " Immunity, vol. 35, no. 5, pp. 792-805, 2011.
112. + T cells, " Nature Immunology, vol. 16, no. 8, pp. 871-879, 2015.
113. T. Dörner and A. Radbruch, "Antibodies and B cell memory in viral immunity, " Immunity, vol. 27, no. 3, pp. 384-392, 2007.
114. N. L. Letvin, "Correlates of immune protection and the development of a human immunodeficiency virus vaccine, " Immunity, vol. 27, no. 3, pp. 366-369, 2007.
115. R. M. Zinkernagel and H. Hengartner, "Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory', " Immunological Reviews, vol. 211, pp. 310-319, 2006.
116. E. Melzi, M. Caporale, M. Rocchi et al., "Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppression, " Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 41, pp. E6238-E6247, 2016.
117. D.D. Richman, T. Wrin, S. J. Little, and C. J. Petropoulos, "Rapid evolution of the neutralizing antibody response to HIV type 1 infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 4144-4149, 2003.
118. X. Wei, J. M. Decker, S. Wang et al., "Antibody neutralization and escape by HIV-1, " Nature, vol. 422, no. 6929, pp. 307-312, 2003.
119. K. Itoh and S. Hirohata, "The role of IL-10 in human B cell activation, proliferation, and differentiation, " Journal of Immunology, vol. 154, no. 9, pp. 4341-4350, 1995.
120. H. Gary-Gouy, J. Harriague, G. Bismuth, C. Platzer, C. Schmitt, and A. H. Dalloul, "Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production, " Blood, vol. 100, no. 13, pp. 4537-4543, 2002.
121. N. Shparago, P. Zelazowski, L. Jin et al., "IL-10 selectively regulates murine Ig isotype switching, " International Immunology, vol. 8, no. 5, pp. 781-790, 1996.
122. F. Malisan, F. Brière, J.-M. Bridon et al., "Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes, " Journal of Experimental Medicine, vol. 183, no. 3, pp. 937-947, 1996.
123. S. Agrawal and S. Gupta, "TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors, " Journal of Clinical Immunology, vol. 31, no. 1, pp. 89-98, 2011.
124. V. Lampropoulou, K. Hoehlig, T. Roch et al., "TLR-activated B cells suppress T cell-mediated autoimmunity, " Journal of Immunology, vol. 180, no. 7, pp. 4763-4773, 2008.
125. A. Sayi, E. Kohler, I. M. Toller et al., "TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells, " Journal of Immunology, vol. 186, no. 2, pp. 878-890, 2011.
126. J. Skok, J. Poudrier, and D. Gray, "Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation ofTh1 development, " Journal of Immunology, vol. 163, no. 8, pp. 4284-4291, 1999.
127. L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora, "IFN-α amplifies human naïve B cell TLR-9-mediated activation and Ig production, " Journal of Leukocyte Biology, vol. 86, no. 2, pp. 261-271, 2009.
128. X. Zhang, E. Deriaud, X. Jiao, D. Braun, C. Leclerc, and R. Lo-Man, "Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells, " Journal of Experimental Medicine, vol. 204, no. 5, pp. 1107-1118, 2007.
129. A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan, "Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, " Immunity, vol. 16, no. 2, pp. 219-230, 2002.
130. K. Yanaba, J.-D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder, "A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, " Immunity, vol. 28, no. 5, pp. 639-650, 2008.
131. K. M. Candando, J. M. Lykken, and T. F. Tedder, "B10 cell regulation of health and disease, " Immunological Reviews, vol. 259, no. 1, pp. 259-272, 2014.
132. J. M. Lykken, K. M. Candando, and T. F. Tedder, "Regulatory B10 cell development and function, " International Immunology, vol. 27, no. 10, pp. 471-477, 2015.
133. N. Matsushita, S. A. Pilon-Thomas, L.M. Martin, and A. I. Riker, "Comparativemethodologies of regulatory T cell depletion in a murine melanoma model, " Journal of Immunological Methods, vol. 333, no. 1-2, pp. 167-179, 2008.
134. A. Yoshizaki, T. Miyagaki, D. J. Dilillo et al., "Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions, " Nature, vol. 491, no. 7423, pp. 264-268, 2012.
135. M. Horikawa, E. T. Weimer, D. J. DiLillo et al., "Regulatory B Cell (B10 Cell) expansion during listeria infection governs innate and cellular immune responses in mice, " Journal of Immunology, vol. 190, no. 3, pp. 1158-1168, 2013.
136. P. Neves, V. Lampropoulou, E. Calderon-Gomez et al., "Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during salmonella typhimurium infection, " Immunity, vol. 33, no. 5, pp. 777-790, 2010.
137. S. Amu, S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger, and P. G. Fallon, "Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model, " Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1114-1124.e8, 2010.
138. Z. Cen, Y. Guo, Q. Kong, Q. Zhou, and W. Wu, "IL-10-producing B cells involved in the pathogenesis of Coxsackie virus B3-induced acute viralmyocarditis, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 1, pp. 830-835, 2015.
139. M. Jones, K. Ladell, K. K. Wynn et al., "IL-10 restricts memory T cell inflation during cytomegalovirus infection, " Journal of Immunology, vol. 185, no. 6, pp. 3583-3592, 2010.
140. R. Madan, F. Demircik, S. Surianarayanan et al., "Nonredundant roles for B cell-derived IL-10 in immune counter-regulation, " Journal of Immunology, vol. 183, no. 4, pp. 2312-2320, 2009.
141. M. B. Mutnal, S. Hu, S. J. Schachtele, and J. R. Lokensgard, "Infiltrating regulatory B cells control neuroinflammation following viral brain infection, " Journal of Immunology, vol. 193, no. 12, pp. 6070-6080, 2014.
142. J. Liu, W. Zhan, C. J. Kim et al., "IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses, " PLoS ONE, vol. 9, no. 2, Article ID e89236, 2014.
143. A. Das, G. Ellis, C. Pallant et al., "IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection, " The Journal of Immunology, vol. 189, no. 8, pp. 3925-3935, 2012.
144. D. D. Naicker, L. Werner, E. Kormuth et al., "Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primaryHIV-1 pathogenesis, " The Journal of Infectious Diseases, vol. 200, no. 3, pp. 448-452, 2009.
145. D. Verhoeven and S. Perry, "Differentialmucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults, " Immunology and Cell Biology, 2016.
146. M. M. N. Tun, K. Aoki, M. Senba et al., "Protective role of TNF-α, IL-10 and IL-2 in mice infected with the Oshima strain of Tick-borne encephalitis virus, " Scientific Reports, vol. 4, article no. 5344, 2014.
147. V. Saxena, A. Mathur, N. Krishnani, and T. N. Dhole, "An insufficient anti-inflammatory cytokine response in mouse brain is associated with increased tissue pathology and viral load during Japanese encephalitis virus infection, " Archives of Virology, vol. 153, no. 2, pp. 283-292, 2008.
148. + Th17 cells, " Journal of Neuroinflammation, vol. 13, no. 1, article 223, 2016.
149. M. T. Lin, D. R. Hinton, B. Parra, S. A. Stohlman, and R. C. Van Der Veen, "The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis, " Virology, vol. 245, no. 2, pp. 270-280, 1998.
150. E. J. Wherry, "T cell exhaustion, " Nature Immunology, vol. 12, no. 6, pp. 492-499, 2011.
151. E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. Van Der Most, and R. Ahmed, "Viral persistence alters CD8 Tcell immunodominance and tissue distribution and results in distinct stages of functional impairment, " Journal of Virology, vol. 77, no. 8, pp. 4911-4927, 2003.
152. D. L. Barber, E. J. Wherry, D. Masopust et al., "Restoring function in exhausted CD8 T cells during chronic viral infection, " Nature, vol. 439, no. 7077, pp. 682-687, 2006.
153. S. D. Blackburn, H. Shin, W. N. Haining et al., "Coregulation of CD8+ T cell exhaustion bymultiple inhibitory receptors during chronic viral infection, " Nature Immunology, vol. 10, no. 1, pp. 29-37, 2009.
154. R. Tinoco, V. Alcalde, Y. Yang, K. Sauer, and E. I. Zuniga, "Cell-intrinsic transforming growth factor-β signalingmediates virus-specific CD8+ T cell deletion and viral persistence in vivo, " Immunity, vol. 31, no. 1, pp. 145-157, 2009.
155. E. B. Wilson and D. G. Brooks, "The role of IL-10 in regulating immunity to persistent viral infections, " Current topics in microbiology and immunology, vol. 350, pp. 39-65, 2011.
156. S. D. Blackburn and E. J. Wherry, "IL-10, T cell exhaustion and viral persistence, " Trends in Microbiology, vol. 15, no. 4, pp. 143-146, 2007.
157. J. K. Flynn, G. J. Dore, M. Hellard et al., "Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users, " Journal of Viral Hepatitis, vol. 18, no. 8, pp. 549-561, 2011.
158. A. De Maria, M. Fogli, S. Mazza et al., "Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients, " European Journal of Immunology, vol. 37, no. 2, pp. 445-455, 2007.
159. E.A. Said, F. P. Dupuy, L. Trautmann et al., "Programmeddeath-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection, " Nature Medicine, vol. 16, no. 4, pp. 452-459, 2010.
160. M. A. Brockman, D. S. Kwon, D. P. Tighe et al., "IL-10 is upregulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells, " Blood, vol. 114, no. 2, pp. 346-356, 2009.
161. N. Sevilla, S. Kunz, A. Holz et al., "Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells, " Journal of ExperimentalMedicine, vol. 192, no. 9, pp. 1249-1260, 2000.
162. N. Sevilla, D. B. McGavern, C. Teng, S. Kunz, and M. B. A. Oldstone, "Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion, " Journal of Clinical Investigation, vol. 113, no. 5, pp. 737-745, 2004.
163. M. B. A. Oldstone, "Biology and pathogenesis of lymphocytic choriomeningitis virus infection, " Current Topics in Microbiology and Immunology, vol. 263, pp. 83-117, 2002.
164. C. T. Ng and M.B.A. Oldstone, "InfectedCD8α-dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 14116-14121, 2012.
165. K. Saito, M. Ait-Goughoulte, S. M. Truscott et al., "Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production, " Journal of Virology, vol. 82, no. 7, pp. 3320-3328, 2008.
166. C.-C. Liang, C.-H. Liu, Y.-L. Lin, C.-J. Liu, B.-L. Chiang, and J.-H. Kao, "Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy, " Journal of Medical Virology, vol. 83, no. 7, pp. 1212-1220, 2011.
167. G. Alter, D. Kavanagh, S. Rihn et al., "IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection, " Journal of Clinical Investigation, vol. 120, no. 6, pp. 1905-1913, 2010.
168. S. Buisson, A. Benlahrech, B. Gazzard, F. Gotch, P. Kelleher, and S. Patterson, "Monocyte-derived dendritic cells from HIV type 1-Infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10, " Journal of Infectious Diseases, vol. 199, no. 12, pp. 1862-1871, 2009.
169. F. Díaz-San Segundo, T. Rodríguez-Calvo, A. de Avila, and N. Sevilla, "Immunosuppression during acute infection with footand-mouth disease virus in swine is mediated by IL-10, " PLoS ONE, vol. 4, no. 5, Article ID e5659, 2009.
170. M. Ostrowski, M. Vermeulen, O. Zabal, J. R. Geffner, A. M. Sadir, and O. J. Lopez, "Impairment of thymus-dependent responses by murine dendritic cells infected with foot-andmouth disease virus, " Journal of Immunology, vol. 175, no. 6, pp. 3971-3979, 2005.
171. N. Sánchez-Sánchez, L. Riol-Blanco, and J. L. Rodríguez-Fernández, "Themultiple personalities of the chemokine receptor CCR7 in dendritic cells, " Journal of Immunology, vol. 176, no. 9, pp. 5153-5159, 2006.
172. + (Foxp3) regulatory T cells in human visceral leishmaniasis, " Journal of Experimental Medicine, vol. 204, no. 4, pp. 805-817, 2007.
173. T. H. Ng, G. J. Britton, E. V. Hill, J. Verhagen, B. R. Burton, and D. C. Wraith, "Regulation of adaptive immunity; the role of interleukin-10, " Frontiers in Immunology, vol. 4, article 129, 2013.
174. C. H. Maris, C. P. Chappell, and J. Jacob, "Interleukin-10 plays an early role in generating virus-specific T cell anergy, " BMC Immunology, vol. 8, article 8, 2007.
175. + T cells, " Journal of Infectious Diseases, vol. 211, no. 5, pp. 769-779, 2015.
176. H. Groux, A. O'Garra, M. Bigler et al., "A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, " Nature, vol. 389, no. 6652, pp. 737-742, 1997.
177. S. Gregori, D. Tomasoni, V. Pacciani et al., "Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway, " Blood, vol. 116, no. 6, pp. 935-944, 2011.
178. S. H. Speck and D. Ganem, "Viral latency and its regulation: lessons from the γ-herpesviruses, " Cell Host and Microbe, vol. 8, no. 1, pp. 100-115, 2010.
179. A. Alcami, "Viral mimicry of cytokines, chemokines and their receptors, " Nature Reviews Immunology, vol. 3, no. 1, pp. 36-50, 2003.
180. A. Alcami and U. H. Koszinowski, "Viral mechanisms of immune evasion, " Trends in Microbiology, vol. 8, no. 9, pp. 410-418, 2000.
181. B. P. McSharry, S. Avdic, and B. Slobedman, "Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation, " Viruses, vol. 4, no. 11, pp. 2448-2470, 2012.
182. K. W. Moore, P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann, "Homology of cytokine synthesis inhibitory factor (IL-10) to the epstein-barr virus gene BCRFI, " Science, vol. 248, no. 4960, pp. 1230-1234, 1990.
183. G. Jayawardane, G. C. Russell, J. Thomson et al., "A captured viral interleukin 10 gene with cellular exon structure, " Journal of General Virology, vol. 89, no. 10, pp. 2447-2455, 2008.
184. E. A. R. Telford, M. S. Watson, H. C. Aird, J. Perry, and A. J. Davison, "The DNA sequence of equine herpesvirus 2, " Journal of Molecular Biology, vol. 249, no. 3, pp. 520-528, 1995.
185. B. Slobedman, P. A. Barry, J. V. Spencer, S. Avdic, and A. Abendroth, "Virus-encoded homologs of cellular interleukin-10 and their control of host immune function, " Journal of Virology, vol. 83, no. 19, pp. 9618-9629, 2009.
186. M. B. Reeves, P. A. MacAry, P. J. Lehner, J. G. P. Sissons, and J. H. Sinclair, "Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 11, pp. 4140-4145, 2005.
187. S. V. Kotenko, S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka, "Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10), " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1695-1700, 2000.
188. C. Jenkins, A. Abendroth, and B. Slobedman, "A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection, " Journal of Virology, vol. 78, no. 3, pp. 1440-1447, 2004.
189. J. V. Spencer, K. M. Lockridge, P. A. Barry et al., "Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10, " Journal of Virology, vol. 76, no. 3, pp. 1285-1292, 2002.
190. S. Avdic, B. P. McSharry, and B. Slobedman, "Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus, " Frontiers in Microbiology, vol. 5, 2014.
191. S. Gordon, "Alternative activation of macrophages, " Nature Reviews Immunology, vol. 3, no. 1, pp. 23-35, 2003.
192. S. Avdic, J. Z. Cao, B. P. McSharry et al., "Human cytomegalovirus interleukin-10 polarizesmonocytes toward a deactivated m2c phenotype to repress host immune responses, " Journal of Virology, vol. 87, no. 18, pp. 10273-10282, 2013.
193. S. Avdic, B. P. McSharry, M. Steain et al., "Human cytomegalovirus-encoded human interleukin-10 (IL-10) homolog amplifies its immunomodulatory potential by upregulating human IL-10 inmonocytes, " Journal of Virology, vol. 90, no. 8, pp. 3819-3827, 2016.
194. M. K. Eberhardt, A. Deshpande, J. Fike et al., "Exploitation of interleukin-10 (IL-10) signaling pathways: alternate roles of viral and cellular IL-10 in rhesus cytomegalovirus infection, " Journal of Virology, vol. 90, no. 21, pp. 9920-9930, 2016.
195. G. M. Mason, S. Jackson, G. Okecha et al., "Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4+ T cells, " PLoS Pathogens, vol. 9, no. 10, Article ID e1003635, 2013.
196. C. Jenkins, W. Garcia, M. J. Godwin et al., "Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection, " Journal of Virology, vol. 82, no. 7, pp. 3736-3750, 2008.
197. J. V. Spencer, J. Cadaoas, P. R. Castillo, V. Saini, and B. Slobedman, "Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10, " Virology, vol. 374, no. 1, pp. 164-169, 2008.
198. L. S. Young and A. B. Rickinson, "Epstein-Barr virus: 40 years on, " Nature Reviews Cancer, vol. 4, no. 10, pp. 757-768, 2004.
199. S. Jochum, A. Moosmann, S. Lang, W. Hammerschmidt, and R. Zeidler, "The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination, " PLOS Pathogens, vol. 8, no. 5, Article IDe1002704, 2012.
200. S. I. Yoon, B. C. Jones, N. J. Logsdon, and M. R. Walter, "Same structure, different function: crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10r1 chain, " Structure, vol. 13, no. 4, pp. 551-564, 2005.
201. S. I. Yoon, B. C. Jones, N. J. Logsdon, B. D. Harris, S. Kuruganti, and M. R. Walter, "Epstein-barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties, " Journal of Biological Chemistry, vol. 287, no. 32, pp. 26586-26595, 2012.
202. P. Vieira, R. DeWaal-Malefyt, M.-N. Dang et al., "Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 4, pp. 1172-1176, 1991.
203. Y. Ding, L. Qin, S. V. Kotenko, S. Pestka, and J. S. Bromberg, "A single amino acid determines the immunostimulatory activity of interleukin 10, " Journal of ExperimentalMedicine, vol. 191, no. 2, pp. 213-224, 2000.
204. G. J. Lindquester, K. A. Greer, J. P. Stewart, and J. T. Sample, "Epstein-Barr virus IL-10 gene expression by a recombinant murine gammaherpesvirus in vivo enhances acute pathogenicity but does not affect latency or reactivation, " Herpesviridae, vol. 5, article 1, 2014.